Investment Centers of America’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-5,025
Closed -$284K 655
2016
Q4
$284K Sell
5,025
-11
-0.2% -$634 0.02% 453
2016
Q3
$311K Buy
+5,036
New +$330K 0.03% 378

Other funds holding PJP

Investment Centers of America's PJP Position: Q1 2017 in Review

Investment Centers of America sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2017, closing a stake of 5,025 shares — an estimated $284K sold.

Investment Centers of America first reported a position in PJP in Q3 2016 and held it in 2 quarters. The position peaked at $311K in Q3 2016. 96 funds tracked by Wall St. Rank hold PJP as of Q1 2017.

  • Investment Centers of America reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2017 after selling out during the quarter.
  • Investment Centers of America sold 5,025 Invesco Pharmaceuticals ETF shares in Q1 2017, an estimated $284K.
  • Investment Centers of America first reported a position in Invesco Pharmaceuticals ETF in Q3 2016 and held it in 2 quarters.
  • Investment Centers of America's Invesco Pharmaceuticals ETF position peaked at $311K in Q3 2016.
  • 96 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2017.

Based on Investment Centers of America's 13F filing for Q1 2017, filed 15 May 2017.